rs774402582

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.5917C>A​(p.Arg1973Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.12

Publications

5 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 12-2688579-C-A is Benign according to our data. Variant chr12-2688579-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 456985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.12 with no splicing effect.
BS2
High AC in GnomAdExome4 at 61 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.6256C>A p.Arg2086Arg synonymous_variant Exon 49 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.6130C>A p.Arg2044Arg synonymous_variant Exon 47 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.6097C>A p.Arg2033Arg synonymous_variant Exon 46 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.6082C>A p.Arg2028Arg synonymous_variant Exon 47 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.6061C>A p.Arg2021Arg synonymous_variant Exon 48 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.6040C>A p.Arg2014Arg synonymous_variant Exon 46 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.6022C>A p.Arg2008Arg synonymous_variant Exon 47 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.6022C>A p.Arg2008Arg synonymous_variant Exon 47 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.6007C>A p.Arg2003Arg synonymous_variant Exon 46 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.6007C>A p.Arg2003Arg synonymous_variant Exon 46 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.6007C>A p.Arg2003Arg synonymous_variant Exon 46 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.6007C>A p.Arg2003Arg synonymous_variant Exon 46 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.6001C>A p.Arg2001Arg synonymous_variant Exon 47 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.5992C>A p.Arg1998Arg synonymous_variant Exon 47 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.5977C>A p.Arg1993Arg synonymous_variant Exon 47 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.5974C>A p.Arg1992Arg synonymous_variant Exon 46 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.5974C>A p.Arg1992Arg synonymous_variant Exon 46 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.5974C>A p.Arg1992Arg synonymous_variant Exon 46 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.5968C>A p.Arg1990Arg synonymous_variant Exon 46 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.5959C>A p.Arg1987Arg synonymous_variant Exon 46 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.5941C>A p.Arg1981Arg synonymous_variant Exon 45 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.5941C>A p.Arg1981Arg synonymous_variant Exon 45 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.5935C>A p.Arg1979Arg synonymous_variant Exon 45 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.5917C>A p.Arg1973Arg synonymous_variant Exon 46 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.5908C>A p.Arg1970Arg synonymous_variant Exon 46 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.5884C>A p.Arg1962Arg synonymous_variant Exon 45 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000161
AC:
4
AN:
248464
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000417
AC:
61
AN:
1461646
Hom.:
0
Cov.:
33
AF XY:
0.0000316
AC XY:
23
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53350
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000504
AC:
56
AN:
1111866
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152224
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41462
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
EpiCase
AF:
0.000218
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 08, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.30
CADD
Benign
5.7
DANN
Benign
0.63
PhyloP100
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs774402582; hg19: chr12-2797745; API